173 related articles for article (PubMed ID: 38074803)
21. Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors.
Fu L; Xie J; Lin J; Wang J; Wei N; Huang D; Wang T; Shen J; Zhou X; Wang Z
Indian J Hematol Blood Transfus; 2017 Dec; 33(4):492-499. PubMed ID: 29075059
[TBL] [Abstract][Full Text] [Related]
22. Late Epstein-Barr virus-related post-transplant lymphoproliferative disorder with intestinal involvement in patient with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hjellbakk HK; Adamska MM; MaŁecki B; BrzeŹniakiewicz-Janus K; Łojko-Dankowska A; Gil L
Cent Eur J Immunol; 2020; 45(2):233-236. PubMed ID: 33456337
[TBL] [Abstract][Full Text] [Related]
23. Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study.
Lückemeier P; Radujkovic A; Holtick U; Kurch L; Monecke A; Platzbecker U; Herling M; Kayser S
Front Oncol; 2023; 13():1208028. PubMed ID: 37427100
[TBL] [Abstract][Full Text] [Related]
24. CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder.
Krishnamoorthy S; Ghobadi A; Santos RD; Schilling JD; Malone AF; Murad H; Bartlett NL; Alhamad T
Am J Transplant; 2021 Feb; 21(2):809-814. PubMed ID: 33089906
[TBL] [Abstract][Full Text] [Related]
25. Posttransplantation lymphoproliferative disorder in children: manifestations in hematopoietic cell recipients in comparison with liver recipients.
Jeon TY; Kim JH; Eo H; Yoo SY; Yoo KH; Lee SK; Lim GY; Cheon JE
Radiology; 2010 Nov; 257(2):490-7. PubMed ID: 20829531
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant lymphoproliferative disorder: Update on treatment and novel therapies.
Atallah-Yunes SA; Salman O; Robertson MJ
Br J Haematol; 2023 May; 201(3):383-395. PubMed ID: 36946218
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years.
Vergote VKJ; Deroose CM; Fieuws S; Laleman W; Sprangers B; Uyttebroeck A; Van Cleemput J; Verhoef G; Vos R; Tousseyn T; Dierickx D
Transpl Int; 2022; 35():10707. PubMed ID: 36589262
[TBL] [Abstract][Full Text] [Related]
28. [The risk factors of post-transplant lymphoproliferative disorders following haploidentical hematopoietic stem cell transplantation].
Zhang C; Huang X; Liu D; Mo X; Zhang X; Chen H; Han W; Chen Y; Wang Y; Wang J; Wang F; Zhao T; Liu Y; Liu K; Xu L
Zhonghua Nei Ke Za Zhi; 2014 Jul; 53(7):527-31. PubMed ID: 25264006
[TBL] [Abstract][Full Text] [Related]
29. Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder.
Sen A; Enriquez J; Rao M; Glass M; Balachandran Y; Syed S; Twist CJ; Weinberg K; Boyd SD; Bernstein D; Trickey AW; Gratzinger D; Tan B; Lapasaran MG; Robien MA; Brown M; Armstrong B; Desai D; Mazariegos G; Chin C; Fishbein TM; Venick RS; Tekin A; Zimmermann H; Trappe RU; Anagnostopoulos I; Esquivel CO; Martinez OM; Krams SM
Front Immunol; 2022; 13():994552. PubMed ID: 36304469
[TBL] [Abstract][Full Text] [Related]
30. Malignant Post-Transplant Lymphoproliferative Disorder of Nasopharynx in Myelodysplastic Disorder.
Luan CW; Chen CC; Lee KF; Tsai MS; Tsai YT; Hsu CM; Chang GH
Healthcare (Basel); 2021 Feb; 9(2):. PubMed ID: 33671238
[TBL] [Abstract][Full Text] [Related]
31. Post-transplant lymphoproliferative disorder of the adrenal gland after allogeneic hematopoietic stem cell transplantation: report of two cases and literature review.
Kasahara H; Mori T; Kato J; Koda Y; Kohashi S; Kikuchi T; Sakurai M; Yamane Y; Mikami S; Kameyama K; Takahashi Y; Okamoto S
Transpl Infect Dis; 2015 Dec; 17(6):909-14. PubMed ID: 26426682
[TBL] [Abstract][Full Text] [Related]
32. EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review.
Liu JY; Zhang JM; Zhan HS; Sun LY; Wei L
Transpl Int; 2021 Dec; 34(12):2483-2493. PubMed ID: 34510581
[TBL] [Abstract][Full Text] [Related]
33. [Clinical Analysis of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients].
Yan HM; Zheng XL; Zhu L; Ding L; Han DM; Liu J; Xue M; Li S; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1224-1229. PubMed ID: 35981389
[TBL] [Abstract][Full Text] [Related]
34. Isolated cerebral post-transplant lymphoproliferative disorder in a lymphoma recipient.
Tang TC; Chuang WY; Chang H
J Cancer Res Ther; 2013; 9(3):534-6. PubMed ID: 24126003
[TBL] [Abstract][Full Text] [Related]
35. [A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation].
Xu LP; Huang XJ; Liu DH; Chen YH; Shi HX; Chen DB
Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):996-9. PubMed ID: 18478915
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.
Choi JH; Park BB; Suh C; Won JH; Lee WS; Shin HJ
J Korean Med Sci; 2010 Apr; 25(4):523-6. PubMed ID: 20357991
[TBL] [Abstract][Full Text] [Related]
37. Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Kline K; Chen W; Kallen ME; Koka R; Omili D; Fan X; Iraguha T; Gebru E; Dishanthan N; Baker JM; Dietze KA; Yared JA; Hankey K; Dahiya S; Niederhaus SV; Dunleavy K; Hardy NM; Luetkens T; Rapoport AP; Atanackovic D
Hum Vaccin Immunother; 2023 Aug; 19(2):2216116. PubMed ID: 37278257
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
[TBL] [Abstract][Full Text] [Related]
39. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
